Melatonin para Sleep-Related Cognitive Impairment

Q: Does Melatonin help with Sleep-Related Cognitive Impairment?

Based on 15 studies with 2,000 participants, there is limited but promising evidence that Melatonin may support Sleep-Related Cognitive Impairment management. Our evidence grade is C (Some Evidence).

Q: How much Melatonin should I take for Sleep-Related Cognitive Impairment?

Studies have used various dosages. A commonly studied range is 0.5-5 mg/day. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Melatonin?

Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Melatonin and Sleep-Related Cognitive Impairment?

We rate the evidence as Grade C (Some Evidence). This rating is based on 15 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Well-established for sleep optimization, melatonin may support cognitive function indirectly by promoting glymphatic clearance of beta-amyloid and other metabolic waste during sleep.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dsleep\u002Dcognitive'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Conclusión

Well-established for sleep optimization, melatonin may support cognitive function indirectly by promoting glymphatic clearance of beta-amyloid and other metabolic waste during sleep.

Key Study Findings

review

Pediatric Insomnia.

Dose: Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other) vs: Placebo Efecto: CBT-I most effective treatment; melatonin beneficial in children with ASD or ADHD; limited evidence None

Other

Banxia Shumi Decoction Improves Sleep and Neural Function in Insomnia Male Rats via BDNF/TrkB/CREB-Dependent Melatonin …

Dose: None vs: PCPA-induced insomnia model control Outcome: Sleep quality and cognitive function in rat model Efecto: None None

Población: PCPA-induced insomnia male rats

Randomized Controlled Trial n=322 5 weeks Double-blind

Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, …

Dose: 20 mg or 50 mg tasimelteon daily vs: Placebo Outcome: Latency to persistent sleep (PSG) Efecto: -44.9 min (20mg) / -46.3 min (50mg) vs -28.2 (placebo) <0.001

Población: Patients with primary insomnia (sleep onset difficulty)

Review

Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment.

Dose: None vs: None Outcome: ISWRD symptom management Efecto: None None

Población: Patients with irregular sleep-wake rhythm disorder

review

Insomnia in older adults: A review of treatment options.

Dose: various vs: Placebo Efecto: None None

Review

Commonly encountered symptoms and their management in patients with cirrhosis.

Dose: None vs: None Outcome: Pain outcomes Efecto: None None

Población: Insomnia patients

Key Statistics

Estudios

2000

Participantes

↑

Positive

Calificación

Referenced Papers

Pediatric Insomnia. Review

Pediatrics in review 2026

Insomnia in older adults: A review of treatment options. Review

Cleveland Clinic journal … 2025 12 citas

Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment. Review

Handbook of clinical … 2025 4 citas

Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial. RCT

PloS one 2025 1 citas

Banxia Shumi Decoction Improves Sleep and Neural Function in Insomnia Male Rats via BDNF/TrkB/CREB-Dependent Melatonin Signaling Activation. Other

Neurochemical research 2025

Interventions for insomnia in cancer patients and survivors-a comprehensive systematic review and meta-analysis. Meta-Analysis

JNCI cancer spectrum 2024 24 citas

Evaluation and management of insomnia in the clinical practice in Italy: a 2023 update from the Insomnia Expert Consensus Group. Review

Journal of neurology 2024 21 citas

Impact of a Novel Valerian Extract on Sleep Quality, Relaxation, and GABA/Serotonin Receptor Activity in a Murine Model. Other

Antioxidants (Basel, Switzerland) 2024 17 citas

Delayed sleep wake phase disorder in adolescents: an updated review. Review

Current opinion in … 2024 12 citas

Commonly encountered symptoms and their management in patients with cirrhosis. Review

Frontiers in medicine 2024 4 citas

[Pharmacotherapies for insomnia]. Other

La Revue du … 2024

Complementary and alternative treatments for insomnia disorder: a systematic umbrella review. Systematic Review

Journal of sleep … 2023 12 citas

RP58 knockdown contributes to hypoxia-ischemia-induced pineal dysfunction and circadian rhythm disruption in neonatal rats. Other

Journal of pineal … 2023 7 citas

Targeting neuroendocrine abnormalities in Parkinson's disease with exercise. Other

Frontiers in neuroscience 2023 5 citas

The Involvement of Melatonin and Tasimelteon against Alzheimer's Disease. Review

Current drug safety 2023 2 citas

Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial. Other

BMJ open 2022 3 citas

Melatonin ameliorates Parkinson's disease via regulating microglia polarization in a RORα-dependent pathway. Other

NPJ Parkinson's disease 2022

Biological rhythms and chronotherapeutics in depression. Review

Progress in neuro-psychopharmacology … 2021 68 citas

Circadian Rhythm Disorders and Corresponding Functional Brain Abnormalities in Young Female Nurses: A Preliminary Study. Other

Frontiers in neurology 2021 16 citas

A Systematic Review of the Efficacy and Safety of Over-the-Counter Medications Used in Older People for the Treatment of Primary … Systematic Review

The Senior care … 2021 12 citas

The role of pineal microRNA-325 in regulating circadian rhythms after neonatal hypoxic-ischemic brain damage. Other

Neural regeneration research 2021 6 citas

Insomnia and menopause: a narrative review on mechanisms and treatments. Review

Climacteric : the … 2020 97 citas

Sleep Issues in Parkinson's Disease and Their Management. Review

Neurotherapeutics : the … 2020 80 citas

Therapy for Insomnia and Circadian Rhythm Disorder in Alzheimer Disease. Review

Current treatment options … 2020 29 citas

The effect of jet lag on the human brain: A neuroimaging study. Other

Human brain mapping 2020 15 citas

Clinical Pearls on Sleep Management in Atopic Dermatitis. Review

Dermatitis : contact, … 2019 7 citas

European guideline for the diagnosis and treatment of insomnia. Other

Journal of sleep … 2017 1691 citas

A review of sleep disorders and melatonin. Review

Neurological research 2017 331 citas

Dietary Sources and Bioactivities of Melatonin. Review

Nutrients 2017 301 citas

Treatment of Sleep Dysfunction in Parkinson's Disease. Review

Current treatment options … 2017 56 citas

Melatonin restores hippocampal neural precursor cell proliferation and prevents cognitive deficits induced by jet lag simulation in adult mice. Other

Journal of pineal … 2017 45 citas

Review of Safety and Efficacy of Sleep Medicines in Older Adults. Review

Clinical therapeutics 2016 328 citas

Pediatric Insomnia. Review

Chest 2016 109 citas

Melatonin has multiorgan effects. Review

European heart journal. … 2016 77 citas

Keeping circadian time with hormones. Review

Diabetes, obesity & … 2015 132 citas

Assessment and treatment of insomnia in adult patients with alcohol use disorders. Review

Alcohol (Fayetteville, N.Y.) 2015 122 citas

Treatment of chronic insomnia disorder in menopause: evaluation of literature. Review

Menopause (New York, … 2015 73 citas

Air travel: effects of sleep deprivation and jet lag. Review

Chest 2013 53 citas

Familial circadian rhythm disorder in the diurnal primate, Macaca mulatta. Other

PloS one 2012 14 citas

Melatonin in experimental seizures and epilepsy. Review

Pharmacological reports : … 2011 99 citas

Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics? Review

Progress in neuro-psychopharmacology … 2011 71 citas

[Insomnias. II. Pharmacological and psychotherapeutic treatment options]. Meta-Analysis

Der Nervenarzt 2009 6 citas

Therapeutic options for sleep-maintenance and sleep-onset insomnia. Review

Pharmacotherapy 2007 117 citas

[Rhythms, depressions and light]. Review

Tidsskrift for den … 2006

Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Other

Brain research. Molecular … 2005 160 citas

Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. Other

Reviews of reproduction 1998 381 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:: 0.5-5 mg/day
sleepcognitivesupport:: 0.5-3 mg 30-60 min before bed

Límite superior: 10 mg/day (higher doses not more effective)

Dosificaciones estudiadas en la investigación

Dosificación	Duración	Efecto	N
Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other)	--	Positive	--
None	--	Positive	--
20 mg or 50 mg tasimelteon daily	5 weeks	Positive	322
None	--	Mixed	--
various	--	Positive	--
None	--	Neutral	--
None	--	Positive	6528
Z-drugs, melatonin, orexin antagonists	--	Positive	--

Mejor momento para tomar: 30-60 minutes before bedtime

Safety & Side Effects

Efectos secundarios reportados

⚠ Daytime drowsiness
⚠ Headache
⚠ Dizziness
⚠ Nausea
⚠ Vivid dreams

Interacciones conocidas

● Sedative medications (additive drowsiness)
● Blood thinners (may increase bleeding risk)
● Diabetes medications (may affect blood sugar)
● Immunosuppressants (may stimulate immune function)
● Oral contraceptives (may increase melatonin levels)

Ingesta máxima tolerable: 10 mg/day (higher doses not more effective)

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Melatonin help with Sleep-Related Cognitive Impairment?

Based on 15 studies with 2,000 participants, there is limited but promising evidence that Melatonin may support Sleep-Related Cognitive Impairment management. Our evidence grade is C (Some Evidence).

How much Melatonin should I take for Sleep-Related Cognitive Impairment?

Studies have used various dosages. A commonly studied range is 0.5-5 mg/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Melatonin?

Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Melatonin and Sleep-Related Cognitive Impairment?

We rate the evidence as Grade C (Some Evidence). This rating is based on 15 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

Otros ingredientes para Sleep-Related Cognitive Impairment

Ashwagandha C L-Theanine C Magnesium L-Threonate C Creatine C

Veredicto rápido

Well-established for sleep optimization, melatonin may support cognitive function indirectly by promoting glymphatic clearance of beta-amyloid and other metabolic waste during sleep.

Evidence Strength52%

Moderate confidence

Desglose de estudios

RCT (1)Meta (2)Other (12)

Comparar alternativas

Vea cómo se comparan otros ingredientes para esta condición.

Ver todos los ingredientes para Sleep-Related Cognitive Impairment

Más información

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.